FDA approves first mRNA flu vaccine

The Food and Drug Administration on Wednesday approved the first mRNA-based influenza vaccine, marking a milestone for the technology, which was first widely used during the COVID-19 pandemic. The vaccine, developed by Moderna, is approved for adults ages 50 to 64 and those 65 and older, who face the highest risk of severe illness from…